News dal mondo
07
Apr
Trump tariff order pushes onshore drug manufacturing longer term: analysts
Leerink Partners analysts see no near-term material changes to U.S. onshoring narrative, given Trump’s executive order late last week on pharmaceutical imports....[PharmaManufacturing]
21
TGA clarifies therapeutic goods are unaffected by chemical production and import ban
TGA has clarified the impact of Australia’s industrial chemicals standards on medicines, medical...
20
US FDA Draft Guidance on Establishing Impurity Specifications for Antibiotics
FDA issued the draft guidance for industry, Establishing Impurity Specifications for Antibiotics. This...
Alfasigma cede a Fine Foods il 100% di Sofar
Alfasigma S.p.A. comunica di aver sottoscritto un accordo per la cessione del 100% del capitale...
17
Sostanze stupefacenti, il Ministero aggiorna le tabelle: inclusa la classe dei Nitazeni tra le sostanze vietate
È stato pubblicato nella Gazzetta Ufficiale il Decreto ministeriale 2 aprile 2026, con il...
le ultime news
03 Feb
China revises drug administration regulations to spur innovation, tighten oversight
02 Feb
USA - A Quality Tax for Foreign Drug Makers? The Links Between National Security, Trade Deals, and Drug Quality.
29 Gen
US FDA Announces PreCheck Implementation Roadmap
28 Gen
Industry wants more streamlining following recent EU reforms
FDA official offers tips on leveraging AI in drug manufacturing
Testo unico legislazione farmaceutica. La delega torna a Palazzo Chigi
27 Gen
Tariff Uncertainty Drives Short-Term Manufacturing Surge as Global Pharmaceuticals Enter Fragmented Growth Phase
23 Gen
Produzione di API: processi, rischi e scenari futuri
<<<6 7
